The HERC proteins and the nervous system

dc.contributor.authorPérez Villegas, Eva María
dc.contributor.authorRuiz, Rocío
dc.contributor.authorBachiller, Sara
dc.contributor.authorVentura Pujol, Francesc
dc.contributor.authorArmengol, José Ángel
dc.contributor.authorRosa López, José Luis
dc.date.accessioned2022-02-17T15:45:39Z
dc.date.available2022-02-17T15:45:39Z
dc.date.issued2021-11-27
dc.date.updated2022-02-17T15:45:39Z
dc.description.abstractThe HERC protein family is one of three subfamilies of Homologous to E6AP C-terminus (HECT) E3 ubiquitin ligases. Six HERC genes have been described in humans, two of which encode Large HERC proteins -HERC1 and HERC2- with molecular weights above 520 kDa that are constitutively expressed in the brain. There is a large body of evidence that mutations in these Large HERC genes produce clinical syndromes in which key neurodevelopmental events are altered, resulting in intellectual disability and other neurological disorders like epileptic seizures, dementia and/or signs of autism. In line with these consequences in humans, two mice carrying mutations in the Large HERC genes have been studied quite intensely: the tambaleante mutant for Herc1 and the Herc2+/530 mutant for Herc2. In both these mutant mice there are clear signs that autophagy is dysregulated, eliciting cerebellar Purkinje cell death and impairing motor control. The tambaleante mouse was the first of these mice to appear and is the best studied, in which the Herc1 mutation elicits: (i) delayed neural transmission in the peripheral nervous system; (ii) impaired learning, memory and motor control; and (iii) altered presynaptic membrane dynamics. In this review, we discuss the information currently available on HERC proteins in the nervous system and their biological activity, the dysregulation of which could explain certain neurodevelopmental syndromes and/or neurodegenerative diseases.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec719131
dc.identifier.issn1084-9521
dc.identifier.pmid34848147
dc.identifier.urihttps://hdl.handle.net/2445/183229
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.semcdb.2021.11.017
dc.relation.ispartofSeminars in Cell & Developmental Biology, 2021, vol. S1084-9521(21), p. 00293-7
dc.relation.urihttps://doi.org/10.1016/j.semcdb.2021.11.017
dc.rightscc-by (c) Rosa Lopez, José Luis et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Ciències Fisiològiques)
dc.subject.classificationProteïnes supressores de tumors
dc.subject.classificationSistema nerviós
dc.subject.classificationDegeneració
dc.subject.classificationMalalties neurodegeneratives
dc.subject.otherTumor suppressor protein
dc.subject.otherNervous system
dc.subject.otherDegeneration
dc.subject.otherNeurodegenerative Diseases
dc.titleThe HERC proteins and the nervous system
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
719131.pdf
Mida:
8.64 MB
Format:
Adobe Portable Document Format